+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Single Cell Multiomics Market by Type, Application, Technique and End User,: Global Opportunity Analysis and Industry Forecast, 2021-2030

  • PDF Icon

    Report

  • 287 Pages
  • June 2021
  • Region: Global
  • Allied Market Research
  • ID: 5439761
Description Jump to:
The global single cell multiomics market was valued at $2,458.80 million in 2020 and is projected to reach $13,908.30 million by 2030, registering a CAGR of 19.0% from 2021 to 2030.



Single cell multiomics technologies typically measure numerous types of molecules from the same individual cell, allowing more profound biological insight than can be inferred by analyzing each molecular layer from separate cells. Furthermore, single cell multiomics technologies can reveal cellular heterogeneity at multiple molecular layers within a population of cells and reveal how this variation is coupled or uncoupled between the captured omic layers. Furthermore, advances in single-cell isolation and barcoding technologies offer unprecedented opportunities to profile DNA, mRNA, and proteins at a single-cell resolution. Recently, bulk multiomics analyses, such as multidimensional genomic and proteogenomic analyses, have proven beneficial for obtaining a comprehensive understanding of cellular events. Moreover, this benefit has facilitated the development of single-cell multiomics analysis, which allows cell type specific gene regulation to be examined.

The factors that drive the single cell multiomics market growth include technological advancements in single-cell analysis products and rise in number of large-scale genomics studies leveraging single-cell RNA Sequencing (sc-RNA). Moreover, increasing adoption of personalized medicine for screening and diagnostics of genetic disorders and rising disposable income in emerging economies drive the growth of the single cell multiomics market. However, high cost of single-cell analysis, dearth of skilled professionals, and integration of data & limited availability of large online data storage and analysis platforms are expected to restrain the growth of the market. Moreover, increasing funding in research of single cell multiomics is anticipated to provide lucrative growth opportunities for market players.

The global single cell multiomics market is segmented on the basis of type, application, technique, end user, and region. On the basis of type, the market is categorized into single cell genomics, single cell proteomics, single cell transcriptomics, and single cell metabolomics. By application, it is classified into oncology, cell biology, neurology, and others. By technique, it is divided into single-cell isolation & dispensing and single-cell analysis. Furthermore, single-cell isolation is further classified into oncology, cell biology, neurology, and others. Moreover, single-cell analysis is further divided into oncology, cell biology, neurology, and others. By end user, it is segmented into academic institutes, contract research organizations, and pharmaceutical & biotech companies. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key benefits for stakeholders

  • The study provides an in-depth analysis of the global single cell multiomics market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
  • Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the key segments of the industry helps understand the applications and products of single cell multiomics used across the globe.
  • Key market players and their strategies have been analyzed to understand the competitive outlook of the market.

KEY MARKET SEGMENTS


By Type

  • Single Cell Genomics
  • Single Cell Proteomics
  • Single Cell Transcriptomics
  • Single Cell Metabolomics

By Application

  • Oncology
  • Cell Biology
  • Neurology
  • Others

By Technique

  • Single-Cell Isolation & Dispensing
  • Oncology
  • Cell Biology
  • Neurology
  • Others
  • Single-Cell Analysis
  • Oncology
  • Cell Biology
  • Neurology
  • Others

By End User

  • Academic Institutes
  • Contract Research Organizations
  • Pharmaceutical & Biotech Companies

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

  • Bio-Rad Laboratories (Celsee, Inc.)
  • BGI Genomics Co. Ltd.
  • Cytiva life science (Previously GE)
  • Fluidigm Corporation
  • Illumina, Inc.
  • 10x Genomics
  • NanoString Technologies
  • MissionBio
  • QIAGEN N.V.
  • Takara Bio

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key Benefits for Stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter’s five force analysis
3.4. Top player positioning, 2020
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Technological advancements in single-cell analysis products
3.5.1.2. Increase in adoption of personalized medicine for the screening and diagnostics of genetic disorders
3.5.2. Restraints
3.5.2.1. High cost of single-cell analysis products
3.5.2.2. Dearth of skilled professionals
3.5.3. Opportunities
3.5.3.1. Increasing funding in the research of single cell multiomics
3.5.4. Impact analysis
3.6. Covid-19 Impact analysis on the single cell multiomics market
CHAPTER 4: SINGLE CELL MULTIOMICS MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Single Cell Genomics
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Single Cell Proteomics
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.4. Single Cell Transcriptomics
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country
4.5. Single Cell Metabolomics
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast
4.5.3. Market analysis, by country
CHAPTER 5: SINGLE CELL MULTIOMICS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Oncology
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Cell Biology
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.4. Neurology
5.4.1. Market size and forecast
5.4.2. Market analysis, by country
5.5. Others
5.5.1. Market size and forecast
5.5.2. Market analysis, by country
CHAPTER 6: SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE
6.1. Overview
6.1.1. Market size and forecast
6.2. Single-Cell Isolation and Dispensing
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.2.3. Market size and forecast, by application
6.2.3.1. Oncology
6.2.3.1.1. Market size and forecast
6.2.3.2. Cell Biology
6.2.3.2.1. Market size and forecast
6.2.3.3. Neurology
6.2.3.3.1. Market size and forecast
6.2.3.4. Others
6.2.3.4.1. Market size and forecast
6.3. Single-Cell Analysis
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.3.3. Market size and forecast, by application
6.3.3.1. Oncology
6.3.3.1.1. Market size and forecast
6.3.3.2. Cell Biology
6.3.3.2.1. Market size and forecast
6.3.3.3. Neurology
6.3.3.3.1. Market size and forecast
6.3.3.4. Others
6.3.3.4.1. Market size and forecast
CHAPTER 7: SINGLE CELL MULTIOMICS MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Academic Institutes
7.2.1. Market size and forecast, by region
7.2.2. Market analysis, by country
7.3. Contract Research Organizations
7.3.1. Market size and forecast, by region
7.3.2. Market analysis, by country
7.4. Pharmaceutical and Biotech Companies
7.4.1. Market size and forecast, by region
7.4.2. Market analysis, by country
CHAPTER 8: SINGLE CELL MULTIOMICS MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast
8.2. North America
8.2.1. Key market trends, growth factors, and opportunities
8.2.2. Market size and forecast, by country
8.2.2.1. U.S. Single cell multiomics market, by type
8.2.2.2. U.S. Single cell multiomics market, by application
8.2.2.3. U.S. Single cell multiomics market, by technique
8.2.2.4. U.S. Single cell multiomics market, by end user
8.2.2.5. Canada Single cell multiomics market, by type
8.2.2.6. Canada Single cell multiomics market, by application
8.2.2.7. Canada Single cell multiomics market, by application
8.2.2.8. Canada Single cell multiomics market, by end user
8.2.2.9. Mexico Single cell multiomics market, by type
8.2.2.10. Mexico Single cell multiomics market, by application
8.2.2.11. Mexico Single cell multiomics market, by application
8.2.2.12. Mexico Single cell multiomics market, by end user
8.2.3. North America market size and forecast, by type
8.2.4. North America market size and forecast, by application
8.2.5. North America market size and forecast, by technique
8.2.5.1. North America single-cell isolation and dispensing, by application
8.2.5.2. North America single-cell analysis, by application
8.2.6. North America market size and forecast, by end user
8.3. Europe
8.3.1. Key market trends, growth factors, and opportunities
8.3.2. Market size and forecast, by country
8.3.2.1. Germany Single cell multiomics market, by type
8.3.2.2. Germany Single cell multiomics market, by application
8.3.2.3. Germany Single cell multiomics market, by application
8.3.2.4. Germany Single cell multiomics market, by end user
8.3.2.5. France Single cell multiomics market, by type
8.3.2.6. France Single cell multiomics market, by application
8.3.2.7. France Single cell multiomics market, by technique
8.3.2.8. France Single cell multiomics market, by end user
8.3.2.9. U.S.ngle cell multiomics market, by type
8.3.2.10. U.S.ngle cell multiomics market, by application
8.3.2.11. U.S.ngle cell multiomics market, by technique
8.3.2.12. U.S.ngle cell multiomics market, by end user
8.3.2.13. Italy Single cell multiomics market, by type
8.3.2.14. Italy Single cell multiomics market, by application
8.3.2.15. Italy Single cell multiomics market, by technique
8.3.2.16. Italy Single cell multiomics market, by end user
8.3.2.17. Spain Single cell multiomics market, by type
8.3.2.18. Spain Single cell multiomics market, by application
8.3.2.19. Spain Single cell multiomics market, by technique
8.3.2.20. Spain Single cell multiomics market, by end user
8.3.2.21. Rest of Europe Single cell multiomics market, by type
8.3.2.22. Rest of Europe Single cell multiomics market, by application
8.3.2.23. Rest of Europe Single cell multiomics market, by technique
8.3.2.24. Rest of Europe Single cell multiomics market, by end user
8.3.3. Europe market size and forecast, by type
8.3.4. Europe market size and forecast, by application
8.3.5. Europe market size and forecast, by technique
8.3.5.1. Europe single-cell isolation and dispensing, by application
8.3.5.2. Europe single-cell analysis, by application
8.3.6. Europe market size and forecast, by end user
8.4. Asia-Pacific
8.4.1. Key market trends, growth factors, and opportunities
8.4.2. Market size and forecast, by country
8.4.2.1. Japan Single cell multiomics market, by type
8.4.2.2. Japan Single cell multiomics market, by application
8.4.2.3. Japan Single cell multiomics market, by technique
8.4.2.4. Japan Single cell multiomics market, by end user
8.4.2.5. China Single cell multiomics market, by type
8.4.2.6. China Single cell multiomics market, by application
8.4.2.7. China Single cell multiomics market, by technique
8.4.2.8. China Single cell multiomics market, by end user
8.4.2.9. Australia Single cell multiomics market, by type
8.4.2.10. Australia Single cell multiomics market, by application
8.4.2.11. Australia Single cell multiomics market, by technique
8.4.2.12. Australia Single cell multiomics market, by end user
8.4.2.13. India Single cell multiomics market, by type
8.4.2.14. India Single cell multiomics market, by application
8.4.2.15. India Single cell multiomics market, by technique
8.4.2.16. India Single cell multiomics market, by end user
8.4.2.17. South Korea Single cell multiomics market, by type
8.4.2.18. South Korea Single cell multiomics market, by application
8.4.2.19. South Korea Single cell multiomics market, by technique
8.4.2.20. South Korea Single cell multiomics market, by end user
8.4.2.21. Rest of Asia-Pacific Single cell multiomics market, by type
8.4.2.22. Rest of Asia-Pacific Single cell multiomics market, by application
8.4.2.23. Rest of Asia-Pacific Single cell multiomics market, by technique
8.4.2.24. Rest of Asia-Pacific Single cell multiomics market, by end user
8.4.3. Asia-Pacific market size and forecast, by type
8.4.4. Asia-Pacific market size and forecast, by application
8.4.5. Asia-Pacific market size and forecast, by technique
8.4.5.1. Asia-Pacific single-cell isolation and dispensing, by application
8.4.5.2. Asia-Pacific single-cell analysis, by application
8.4.6. Asia-Pacific market size and forecast, by end user
8.5. LAMEA
8.5.1. Key market trends, growth factors, and opportunities
8.5.2. Market size and forecast, by country
8.5.2.1. Brazil Single cell multiomics market, by type
8.5.2.2. Brazil Single cell multiomics market, by application
8.5.2.3. Brazil Single cell multiomics market, by technique
8.5.2.4. Brazil Single cell multiomics market, by end user
8.5.2.5. Saudi Arabia Single cell multiomics market, by type
8.5.2.6. Saudi Arabia Single cell multiomics market, by application
8.5.2.7. Saudi Arabia Single cell multiomics market, by technique
8.5.2.8. Saudi Arabia Single cell multiomics market, by end user
8.5.2.9. Rest of LAMEA Single cell multiomics market, by type
8.5.2.10. Rest of LAMEA Single cell multiomics market, by application
8.5.2.11. Rest of LAMEA Single cell multiomics market, by technique
8.5.2.12. Rest of LAMEA Single cell multiomics market, by end user
8.5.3. LAMEA market size and forecast, by type
8.5.4. LAMEA market size and forecast, by application
8.5.5. LAMEA market size and forecast, by technique
8.5.5.1. LAMEA single-cell isolation and dispensing, by application
8.5.5.2. LAMEA single-cell analysis, by application
8.5.6. LAMEA market size and forecast, by end user
CHAPTER 9: COMPANY PROFILES
9.1. BGI Genomics Co. Ltd.
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product portfolio
9.1.5. Business performance
9.1.6. Key strategic moves and developments
9.2. Bio-Rad Laboratories, Inc.
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Product portfolio
9.2.5. Business performance
9.2.6. Key strategic moves and developments
9.3. Danaher Corporation (Cytiva Life sciences)
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Product portfolio
9.3.5. Business performance
9.3.6. Key strategic moves and developments
9.4. Fluidigm Corporation
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product portfolio
9.4.5. Business performance
9.4.6. Key strategic moves and developments
9.5. Illimina Inc.
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product portfolio
9.5.5. Business performance
9.6. Mission Bio, Inc.
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product portfolio
9.6.5. Key strategic moves and developments
9.7. NanoString Technologies, Inc
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product portfolio
9.7.5. Business performance
9.7.6. Key strategic moves and developments
9.8. Qiagen N. V.
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Product portfolio
9.8.5. Business performance
9.8.6. Key strategic moves and developments
9.9. Takara Holdings Inc. (Takara Bio Group)
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Product portfolio
9.9.5. Business performance
9.9.6. Key strategic moves and developments
9.10.10x Genomics, Inc.
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product portfolio
9.10.5. Business performance
9.10.6. Key strategic moves and developments
List of Tables
TABLE 01. GLOBAL SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 02. SINGLE CELL GENOMICS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 03. SINGLE CELL PROTEOMICS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 04. SINGLE CELL TRANSCRIPTOMICSMARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 05. SINGLE CELL METABOLOMICS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 06. GLOBAL SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 07. ONCOLOGY MARKET, BY REGION, 2020-2030($MILLION)
TABLE 08. CELL BIOLOGY MARKET, BY REGION, 2020-2030($MILLION)
TABLE 09. NEUROLOGY MARKET, BY REGION, 2020-2030($MILLION)
TABLE 10. OTHERS MARKET, BY REGION, 2020-2030($MILLION)
TABLE 11. GLOBAL SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030($MILLION)
TABLE 12. SINGLE-CELL ISOLATION AND DISPENSING MARKET, BY REGION, 2020-2030($MILLION)
TABLE 13. SINGLE-CELL ISOLATION AND DISPENSING, BY APPICATION, 2020–2030 ($MILLION)
TABLE 14. SINGLE-CELL ANALYSIS MARKET, BY REGION, 2020-2030($MILLION)
TABLE 15. SINGLE-CELL ANALYSIS, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 16. GLOBAL SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 17. ACADEMIC INSTITUTES MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 18. CONTRACT RESEARCH ORGANIZATIONS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 19. PHARMACEUTICAL AND BIOTECH COMPANIES MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 20. GLOBAL SINGLE CELL MULTIOMICS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 21. NORTH AMERICA SINGLE CELL MULTIOMICS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 22. U.S. SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 23. U.S. SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 24. U.S. SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 25. U.S. SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 26. CANADA SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 27. CANADA SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 28. CANADA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 29. CANADA SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 30. MEXICO SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 31. MEXICO SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 32. MEXICO SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 33. MEXICO SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 34. NORTH AMERICA SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 35. NORTH AMERICA SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 36. NORTH AMERICA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 37. NORTH AMERICA SINGLE-CELL ISOLATION AND DISPENSING, BY APPLICATION, 2020-2030
TABLE 38. NORTH AMERICA SINGLE-CELL ANALYSIS, BY APPLICATION, 2020-2030
TABLE 39. NORTH AMERICA SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 40. EUROPE SINGLE CELL MULTIOMICS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 41. GERMANY SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 42. GERMANY SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 43. GERMANY SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 44. GERMANY SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 45. FRANCE SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 46. FRANCE SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 47. LAMEA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 48. FRANCE SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 49. UK SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 50. UK SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 51. UK SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 52. UK SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 53. ITALY SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 54. ITALY SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 55. ITALY SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 56. ITALY SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 57. SPAIN SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 58. SPAIN SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 59. LAMEA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 60. SPAIN SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 61. REST OF EUROPE SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 62. REST OF EUROPE SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 63. REST OF EUROPE SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 64. REST OF EUROPE SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 65. EUROPE SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 66. EUROPE SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 67. EUROPE SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 68. EUROPE SINGLE-CELL ISOLATION AND DISPENSING, BY APPLICATION, 2020-2030
TABLE 69. EUROPE SINGLE-CELL ANALYSIS, BY APPLICATION, 2020-2030
TABLE 70. EUROPE SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 71. ASIA-PACIFIC SINGLE CELL MULTIOMICS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 72. JAPAN SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 73. JAPAN SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 74. LAMEA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 75. JAPAN SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 76. CHINA SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 77. CHINA SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 78. LAMEA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 79. CHINA SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 80. AUSTRALIA SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 81. AUSTRALIA SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 82. AUSTRALIA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 83. AUSTRALIA SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 84. INDIA SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 85. INDIA SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 86. INDIA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 87. INDIA SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 88. SOUTH KOREA SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 89. SOUTH KOREA SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 90. SOUTH KOREA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 91. SOUTH KOREA SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 92. REST OF ASIA-PACIFIC SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 93. REST OF ASIA-PACIFIC SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 94. REST OF ASIA-PACIFIC SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 95. REST OF ASIA-PACIFIC SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 96. ASIA-PACIFIC SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 97. ASIA-PACIFIC SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 98. ASIA-PACIFIC SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 99. ASIA-PACIFIC SINGLE-CELL ISOLATION AND DISPENSING, BY APPLICATION, 2020-2030
TABLE 100. ASIA-PACIFIC SINGLE-CELL ANALYSIS, BY APPLICATION, 2020-2030
TABLE 101. ASIA-PACIFIC SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 102. LAMEA SINGLE CELL MULTIOMICS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 103. BRAZIL SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 104. BRAZIL SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 105. BRAZIL SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 106. BRAZIL SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 107. SAUDI ARABIA SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 108. SAUDI ARABIA SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 109. SAUDI ARABIA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 110. SAUDI ARABIA SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 111. REST OF LAMEA SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 112. REST OF LAMEA SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 113. LAMEA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 114. REST OF LAMEA SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 115. LAMEA SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 116. LAMEA SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 117. LAMEA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 118. LAMEA SINGLE-CELL ISOLATION AND DISPENSING, BY APPLICATION, 2020-2030
TABLE 119. LAMEA SINGLE-CELL ANALYSIS, BY APPLICATION, 2020-2030
TABLE 120. LAMEA SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 121. BGI GENOMICS: COMPANY SNAPSHOT
TABLE 122. BGI GENOMICS: PRODUCT PORTFOLIO
TABLE 123. BGI GENOMICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 124. BIO-RAD: COMPANY SNAPSHOT
TABLE 125. BIO-RAD: OPERATING SEGMENTS
TABLE 126. BIO-RAD: PRODUCT PORTFOLIO
TABLE 127. BIO-RAD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 128. DANAHER: COMPANY SNAPSHOT
TABLE 129. DANAHER: OERATING SEGMENT
TABLE 130. DANAHER: PRODUCT PORTFOLIO
TABLE 131. DANAHER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 132. FLUIDIGM: COMPANY SNAPSHOT
TABLE 133. FLUIDIGM: OPERATING SEGMENTS
TABLE 134. FLUIDIGM: PRODUCT PORTFOLIO
TABLE 135. FLUIDIGM: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 136. ILLUMINA: COMPANY SNAPSHOT
TABLE 137. ILLUMINA: OERATING SEGMENT
TABLE 138. ILLUMINA: PRODUCT PORTFOLIO
TABLE 139. MISSION BIO: COMPANY SNAPSHOT
TABLE 140. MISSION BIO: OPERATING SEGMENTS
TABLE 141. MISSION BIO: PRODUCT PORTFOLIO
TABLE 142. MISSION BIO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 143. NANOSTRING TECHNOLOGIES: COMPANY SNAPSHOT
TABLE 144. NANOSTRING TECHNOLOGIES: OPERATING SEGMENTS
TABLE 145. NANOSTRING TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 146. NANOSTRING TECHNOLOGIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 147. QIAGEN: COMPANY SNAPSHOT
TABLE 148. QIAGEN: OERATING SEGMENT
TABLE 149. QIAGEN: PRODUCT PORTFOLIO
TABLE 150. QIAGEN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 151. TAKARA HOLDINGS: COMPANY SNAPSHOT
TABLE 152. TAKARA HOLDINGS: PRODUCT PORTFOLIO
TABLE 153. TAKARA HOLDINGS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 154.10 X GENOMICS: COMPANY SNAPSHOT
TABLE 155.10 X GENOMICS: OERATING SEGMENT
TABLE 156.10 X GENOMICS.: PRODUCT PORTFOLIO
TABLE 157.10 X GENOMICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
List of Figures
FIGURE 01. GLOBAL SINGLE CELL MULTIOMICS MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2018–2021
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021 (%)
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2018–2021
FIGURE 06. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07. MODERATE BARGAINING POWER OF BUYERS
FIGURE 08. MODERATE THREAT OF SUBSTITUTES
FIGURE 09. HIGH THREAT OF NEW ENTRANTS
FIGURE 10. MODERATE INTENSITY OF RIVALRY
FIGURE 11. TOP PLAYER POSITIONING, 2020
FIGURE 12. IMPACT ANALYSIS
FIGURE 13. COMPARATIVE ANALYSIS OF SINGLE CELL PROTEOMICSMARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 14. COMPARATIVE ANALYSIS OF BANDAGE SINGLE CELL PROTEOMICS MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 15. COMPARATIVE ANALYSIS OF SINGLE CELL TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 16. COMPARATIVE ANALYSIS OF SINGLE CELL METABOLOMICS MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 17. COMPARATIVE ANALYSIS OF ONCOLOGY MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 18. COMPARATIVE ANALYSIS OF CELL BIOLOGY MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 19. COMPARATIVE ANALYSIS OF NEUROLOGY MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 20. COMPARATIVE ANALYSIS OF OTHERS MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 21. COMPARATIVE ANALYSIS OF SINGLE-CELL ISOLATION AND DISPENSING MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 22. ONCOLOGY MARKET, 2020–2030 ($MILLION)
FIGURE 23. CELL BIOLOGY MARKET, 2020–2030 ($MILLION)
FIGURE 24. NEUROLOGY MARKET, 2020–2030 ($MILLION)
FIGURE 25. OTHERS MARKET, 2020–2030 ($MILLION)
FIGURE 26. COMPARATIVE ANALYSIS OF SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 27. ONCOLOGY MARKET, 2020–2030 ($MILLION)
FIGURE 28. CELL BIOLOGY MARKET, 2020–2030 ($MILLION)
FIGURE 29. NEUROLOGY MARKET, 2020–2030 ($MILLION)
FIGURE 30. OTHERS MARKET, 2020–2030 ($MILLION)
FIGURE 31. COMPARATIVE ANALYSIS OF HOSPITAL AND CLINIC SINGLE CELL MULTIOMICS MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 32. COMPARATIVE ANALYSIS OF CONTRACT RESEARCH ORGANIZATIONS MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 33. COMPARATIVE ANALYSIS OF PHARMACEUTICAL AND BIOTECH COMPANIES MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 34. BGI GENOMICS: NET SALES, 2018–2020 ($MILLION)
FIGURE 35. BIO-RAD: NET SALES, 2018–2020 ($MILLION)
FIGURE 36. BIO-RAD: REVENU.S.ARE BY SEGMENT, 2020 (%)
FIGURE 37. BIO-RAD: REVENU.S.ARE BY REGION, 2020 (%)
FIGURE 38. DANAHER: NET SALES, 2018–2020 ($MILLION)
FIGURE 39. DANAHER: REVENU.S.ARE BY SEGMENT, 2020 (%)
FIGURE 40. DANAHER: REVENU.S.ARE BY REGION, 2020 (%)
FIGURE 41. FLUIDIGM: NET SALES, 2018–2020 ($MILLION)
FIGURE 42. FLUIDIGM: REVENU.S.ARE BY REGION, 2020 (%)
FIGURE 43. ILLUMINA: NET SALES, 2018–2020 ($MILLION)
FIGURE 44. ILLUMINA: REVENU.S.ARE BY REGION, 2020 (%)
FIGURE 45. NANOSTRING TECHNOLOGIES: NET SALES, 2018–2020 ($MILLION)
FIGURE 46.10X GENOMICS: REVENU.S.ARE BY REGION, 2020 (%)
FIGURE 47. QIAGEN: NET SALES, 2018–2020 ($MILLION)
FIGURE 48. QIAGEN: REVENU.S.ARE BY REGION, 2020 (%)
FIGURE 49. TAKARA HOLDINGS: NET SALES, 2018–2020 ($MILLION)
FIGURE 50. TAKARA HOLDINGS: REVENU.S.ARE BY REGION, 2020 (%)
FIGURE 51.10X GENOMICS: NET SALES, 2018–2020 ($MILLION)
FIGURE 52.10X GENOMICS: REVENU.S.ARE BY REGION, 2020 (%)

Companies Mentioned

  • Bio-Rad Laboratories (Celsee Inc.)
  • BGI Genomics Co. Ltd.
  • Cytiva Life Science (Previously GE)
  • Fluidigm Corporation
  • Illumina Inc.
  • 10x Genomics
  • NanoString Technologies
  • MissionBio
  • QIAGEN N.V.
  • Takara Bio.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages287
PublishedJune 2021
Forecast Period2020 - 2030
Estimated Market Value ( USD ) in 2020 $ 2458.8 million
Forecasted Market Value ( USD ) by 2030 $ 13908.3 million
Compound Annual Growth Rate18.9%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Global Multiomics Market Size, Share & Industry Trends Analysis Report By Type (Bulk Multiomics, and Single-cell Multiomics), By Product & Service, By End-use, By Platform, By Application, By Regional Outlook and Forecast, 2023 - 2030 - Product Image

Global Multiomics Market Size, Share & Industry Trends Analysis Report By Type (Bulk Multiomics, and Single-cell Multiomics), By Product & Service, By End-use, By Platform, By Application, By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • Global
From
LAMEA Multiomics Market Size, Share & Industry Trends Analysis Report By Type (Bulk Multiomics, and Single-cell Multiomics), By Product & Service, By End-use, By Platform, By Application, By Country and Growth Forecast, 2023 - 2030 - Product Image

LAMEA Multiomics Market Size, Share & Industry Trends Analysis Report By Type (Bulk Multiomics, and Single-cell Multiomics), By Product & Service, By End-use, By Platform, By Application, By Country and Growth Forecast, 2023 - 2030

  • Report
  • Africa, Middle East
From
Multiomics Market Size, Share & Trends Analysis Report By Product & Service (Instruments, Consumables), By Type (Single-cell, Bulk), By Platform, By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Multiomics Market Size, Share & Trends Analysis Report By Product & Service (Instruments, Consumables), By Type (Single-cell, Bulk), By Platform, By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 180 Pages
  • Global
From
Global Multiomics Market Analysis & Forecast to 2024-2034 - Product Image

Global Multiomics Market Analysis & Forecast to 2024-2034

  • Report
  • 200 Pages
  • Global
From
Global Multiomics Market by Product (Consumables, Instrument, Software), Type (Epigenomics, Genomics, Metabolomics), Application, End-User - Forecast 2024-2030 - Product Image

Global Multiomics Market by Product (Consumables, Instrument, Software), Type (Epigenomics, Genomics, Metabolomics), Application, End-User - Forecast 2024-2030

  • Report
  • 198 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.